Modification of carboxypeptidase A7 crystals (Anson) with diazotized arsanilic acid specifically labels tyrosine 248; at pH 8.2 the modified enzyme gives yellow crystals, but a red solution. It has been suggested that arsanilazotyrosine 248 forms a complex with the Zn cofactor accounting for the red color in solution, but that a complex is not formed in the crystal. However, the crystal structure of carboxypeptidase A7 is unknown. We show here that crystals of carboxypeptidase Aa, whose crystal structure has been determined, are red both in solution and in the crystalline state (at pH 8.2) after modification with diazotized arsanilic acid. These new data are of importance in relating the structure in the crystalline state to the catalytic mechanisms, as based on the x-ray diffraction evidence.
boxypeptidase A. at pH 6.7 (yellow) is increased to pH 8.5 (red). The rate constants obtained in this experiment are 6.1!sec-l at 3 .0 mg/ml and 7.2 sec'1 at 1.6 mg/ml concentration of enzyme.
The relationship of the three-dimensional structure to biological function of carboxypeptidase A (CPA; EC 3.4.2.1), a proteolytic enzyme that cleaves most C-terminal amino acids from peptide substrates, has been correlated (1) . In particular, the three-dimensional structure of CPAa* indicates that there are 307 amino acids (2) in the single chain, that the cofactor Zn++ is near the active site, and that there are only two side chains (Glu 270 and Tyr 248) of the enzyme that can approach within Van der Waals contact with atoms of the substrate at the bond to be cleaved (3) . The structure of native CPA,, at pH 7.5 and 40 shows that the OH group of Tyr 248 is some 1.2 nm (12 A) away from the position to which it moves when a substrate such as glycyl-ityrosine is bound. Comparison of the activity of CPA7, which has seven fewer amino acids at the N-terminus than does CPAa) in solution and crystalline states, has shown that at pH 7.5 and low ionic strength the maximum specific activity of small crystals is less than that in solution by a factor of 300 (4) .
Recently, Vallee (12) .
In the modification experiments, uniform microcrystals were reacted with diazotized arsanilic acid (6) , and then were washed with 0.01 M KHCO3 (pH 8.5) because we found that the recommended procedure of washing with water (6) (15) , shown in Fig (Fig. 3) . The same result was obtained with crystalline preparations that had the same crystal form (elongated along the b axis) as the commercial form, but were obtained by the method used for the crystals obtained in the x-ray analysis. The number of arsanilazo groups per enzyme molecule was close to unity (0.85-0.95) in these and subsequent experiments described below for CPAa. All at p11 8.2 (Figs. 4 and 5A) . At pH 7.5 (40), at which the crystal structure was determined, Tyr 248 is away from the active site; at this same pH the crystals and solution of arsanilazo Tyr 248 CPAa are nearly yellow (Figs. 4 and  5A ). We therefore caution against a general interpretation of the results of Vallee et al., and we also suggest that their results for CPAz are not readily interpretable in terms of the known crystal structure of CPAa.
The red color at pH 8.2 of either crystals or solution of CPAa can be changed to yellow by (a) lowering of the pH to 7.4 (Figs. 4 and 5A), (b) addition of a chelating agent, 1,10 phenanthroline, (c) addition of a substrate glycyl-L-tyrosine, or (d) addition of the inhibitor L-phenylalanine.
Measurements of the pKa of the pH change at 510 nm in solution yielded 7.78 + 0.04 for modified CPAa (Fig. 5B ) and 7.72 ±-0.04 for modified CPA. For modified CPAa crystals, roughly the same value was found. Results of the pH-jump, stopped-flow experiment (pH 6.7-8.4) described above yielded, for the single exponential rate observed, rate constants of 6.1 sec-' (Fig. 6 ) and 7.2 sec-' at enzyme (CPAa) concentrations of 3.0 mg/ml and 1.6 mg/ml, respectively. It is probable that this rate reflects an ionizationinduced conformational change of the modified tyrosine 248, from the yellow arsanilazotyrosine to the red form of arsanilazotyrosine. Since one would expect the simple ionization of the arsanilazo tyrosine 248 to be fast, and incapable of being detected by the technique used in these experiments, the rates we are observing must reflect some slow rate-limiting process. Similarly, the observed pKa will not be the direct simple ionization of the arsanilazotyrosine but will be the PKa of this rate-limiting process. The assignment of a unique step to this process cannot yet be made: some of the possibilities are (a) movement of Tyrosine 248 to the active site (Fig. 7a) In the absence of a definitive x-ray diffraction study of arsanilazotyrosine-248 CPA, we are unsure of the structural interpretation of the color behavior, but this behavior is the same for our modified CPAa in both the crystal and solution.
Although no general statement can be made about comparisons of behavior of enzymes and other proteins in the crystal and in solution, the excellent review by Rupley (18) indicates that kinetic parameters are more likely to be affected than are equilibrium thermodynamic parameters. Indeed, the fact that enzymatic activity can be observed at all in the crystal is due to the large proportion of solvent in the crystal structure. Also, the active site is usually in a crevice or depression in the enzyme surface, and therefore is less likely to be in regions of intermolecular contact than other parts of the molecule. Our results here indicate a striking difference between the behavior of crystals of modified CPA, and crystals of modified CPA-in a spectral change. Also, enzymatic activities of crystals of CPAa and of CPAz are quite different. We therefore suggest that when activity is strongly modified in crystals of one type, it may be possible to find another type of crystal in which the modification of activity is considerably less. However, this procedure may not be helpful if very large conformational shifts occur among subunits of an enzyme complex.
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